drug
as of 2026-07-01modafinil
Modafinil
MeSH D000077408
at a glance
small molecule
Pre-approval / investigational in the US
Developed by University of Minnesota
10 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
10
Cognitive Strategies in Early Psychosis 2
NCT07263022Phase 3Not Yet Recruiting
Cognitive Strategies in Early Psychosis 1
NCT07231497Phase 3Recruiting
Touchscreen-based Cognitive Tests in Healthy Volunteers
NCT03469089Phase 1Unknown
Effects of Modafinil on Brain Function in Patients With Schizophrenia
NCT00057707Phase 1Completed
Antipsychotic Effects on Brain Function in Schizophrenia
NCT01913327Phase 4Terminated
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
NCT00423943Phase 4Completed
Modafinil Augmentation in Chronic Schizophrenia and Schizoaffective Disorder
NCT00838227Phase 2Withdrawn
Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia
NCT00314639Phase 1, Phase 2Completed
Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With Schizophrenia
NCT00546403—Completed
A Placebo-Controlled Trial of Modafinil (Provigil) Added to Clozapine in Patients With Schizophrenia
NCT00573417Phase 4Completed
KOLs & investigators
10
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
trial
trial
indication
indication
indication
indication
indication
KOL
Donald C. Goff, MD
personKOL score 8
Sophia Vinogradov, MD
personKOL score 5
Caroline Cellard, Ph.D
personKOL score 5
Jean-Pierre Lindenmayer, MD
personKOL score 5